Infectious Disease Diagnostics
Featured Products
Quidel® Molecular diagnostic kits are FDA-cleared, CE-IVD–labelled, real-time PCR assays for the qualitative detection and identification of these infectious agents:
| Influenza A + B (FDA-Cleared/CE-IVD) |
C. difficile |
||
| Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) (FDA-Cleared/CE-IVD) |
HSV 1+ 2/VZV |
||
|
|||
The kits offer accurate, rapid results as well as streamlined workflows, and are validated for use on the QuantStudio™ Dx Real-Time PCR instrument, and the 7500 Fast Dx Real-time PCR Systems.
Featured Instruments
Benefits of Quidel® Diagnostic Kits
| Features | Benefits |
|---|---|
| One-step reagent preparation | Just add rehydration solution to the lyophilized master mix and pipette it into the assay plate |
| Simplified storage requirements | The kits are designed for refrigerator storage (2–8°C) and have up to a 2-year shelf life from date of manufacture |
| Room-temperature setup | The assay is setup at room temperature; no ice or cooling blocks are required |
| Rapid results | Assay results are typically available in less than 75 minutes after extraction of the sample (60 minutes for the Direct C. difficile Assay) |
| Common internal control | All Quidel® kits use a common internal PCR control and common cycling parameters, which allows extracted samples to be assayed with any of the Quidel® kits and also allows different assays to be run on the same plate Regulatory—the kits conform to GMP, CE-IVD, and FDA requirements (Not all Quidel® diagnostic kits are available in the US: see individual products for details.) |
| Flexible format | Kits include vials of 12 x 8 master mix, rehydration solution, and liquid process controls |
